KPV is a synthetic tripeptide (Lys-Pro-Val) derived from the C-terminal fragment of alpha-melanocyte-stimulating hormone ($\alpha$-MSH) that targets anti-inflammatory and antimicrobial pathways without inducing skin pigmentation. It is researched primarily in preclinical models for its role in cellular repair, dermal regeneration, and gastrointestinal homeostasis. This investigational substance is not FDA-approved and is classified strictly for research purposes.